Showing results (51-60 of 209) with videos related to

Sort By:
Pageof 21
Journal of Hepatology|April 26, 2020
Hepatitis B surface antigen seroclearance: Immune mechanisms, clinical impact, importance for drug developmentIssam Tout, Dimitri Loureiro, Abdellah Mansouri, et al.
Journal of Hepatology|June 25, 2003
Prolonged cholestasis and ductopenia associated with tenoxicamViviane Trak-Smayra, Dominique Cazals-Hatem, Tarik Asselah, et al.
Seminars in Liver Disease|February 14, 2007
Genetics, genomics, and proteomics: implications for the diagnosis and the treatment of chronic hepatitis CTarik Asselah, Ivan Bièche, Valérie Paradis, et al.
Antiviral Research|May 7, 2026
Understanding HBV immunopathogenesis to inform future immune-based therapiesMargaux Bossis, Phuong-Ha Le, Tarik Asselah, et al.
Alimentary Pharmacology & Therapeutics|March 16, 2022
Review article: emerging insights into the immunopathology, clinical and therapeutic aspects of hepatitis delta virusCarla Usai, Upkar S Gill, Anna C Riddell, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|February 8, 2006
The current status of antiviral therapy of chronic hepatitis BTarik Asselah, Marie-Pierre Ripault, Corinne Castelnau, et al.
Viruses|December 17, 2020
miRNAs as Potential Biomarkers for Viral Hepatitis B and CDimitri Loureiro, Issam Tout, Stéphanie Narguet, et al.
European Journal of Gastroenterology & Hepatology|August 9, 2006
Hepatitis C virus eradication followed by HBeAg to anti-HBe seroconversion after pegylated interferon-alpha2b plus ribavirin treatment in a patient with hepatitis B and C coinfectionPierre-Emmanuel Rautou, Tarik Asselah, David Saadoun, et al.
European Journal of Gastroenterology & Hepatology|March 19, 2004
Multifactorial aetiology of hepatic infarction: a case report with literature reviewSven Francque, Bertrand Condat, Tarik Asselah, et al.
Pageof 21